Home / Stocks / Parnax Lab Ltd.
PARNAXLAB

Parnax Lab Ltd. Share Price

Live price, chart and which mutual funds hold this stock

…

as of —

₹—

Change

—

Day Open

₹—

Day High

₹—

Day Low

₹—

NSE Close — 19 Nov 2026

₹113.41

Change

-3.01 (-2.59%)

Open

₹119.0

Prev. Close

₹116.42

Day High

₹124.69

Day Low

₹110.5

Volume Analysis

Traded

4,352

Delivered

3,886

Delivery %

89.29%

End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.

Pivot Levels

Type R3 R2 R1 Pivot S1 S2 S3
Classic ₹136.09 ₹130.39 ₹121.9 ₹116.2 ₹107.71 ₹102.01 ₹93.52
Fibonacci ₹130.39 ₹124.97 ₹121.62 ₹116.2 ₹110.78 ₹107.43 ₹102.01
Camarilla ₹117.31 ₹116.01 ₹114.71 ₹116.2 ₹112.11 ₹110.81 ₹109.51

Support/resistance levels for today, calculated from the previous trading day's high/low/close.

Absolute Returns

YTD

—

1 Week

+5.01%

1 Month

+9.11%

3 Months

-11.26%

6 Months

—

1 Year

—

2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.

Stock Vitals

Computed from the latest available annual financials.

Graham Number

₹140.16

Current price is at or below the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.

DuPont ROE Breakdown

7.94%

Net margin 3.09% × asset turnover 1.0x × equity multiplier 2.57x

Company Overview

Sector

Healthcare

Market Cap

₹125 Cr

P/E (TTM)

14.6

ROE

14.2%

Book Value

₹85.1

Face Value

₹10.0

Source: Screener.in (Consolidated figures) — data as of 16 Nov 2026. Not investment advice.

TopFund Analysis

Parnax Lab Ltd. lands in the middle of the pack on TopFund's composite fundamentals check within the Healthcare sector, at 53/100. The strongest factor is Growth (75/100), while Momentum (20/100) is the weakest area to weigh before deciding.

TopFund Score — Fundamentals Quality

53/100 — Average

Data confidence: 75/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.

As of 19 Nov 2026 · How we calculate this →

Financial Strength

68

Growth

75

Valuation

69

Cash Flow

30

Corporate Governance

56

Momentum

20

Business Quality

49

Risk & Volatility

37

Liquidity

50

From Screener.in

  • −Though the company is reporting repeated profits, it is not paying out dividend

Not investment advice — an automated read of public fundamentals data, for research context only.

Corporate Actions

Source: BSE regulatory filings, via Screener.in.

Quarterly Results

Last several quarters

  Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Sales + 43 51 46 50 48 40 49 53 63 63 70 57 69
Expenses + 37 45 41 42 41 36 42 46 55 56 65 52 62
Operating Profit 5 6 6 9 7 4 7 7 8 7 5 4 7
OPM % 12.41% 11.71% 12.49% 17.2% 14.97% 10.62% 13.52% 13.94% 12.91% 10.88% 7.01% 7.59% 9.96%
Other Income + 0 0 0 0 1 0 0 0 1 0 2 0 0
Interest 1 1 1 2 1 1 1 1 1 1 2 2 2
Depreciation 2 2 2 2 2 2 2 2 2 2 2 2 2
Profit before tax 2 3 3 5 5 1 4 4 5 3 3 1 3
Tax % 20.09% 25.85% 19.35% 26.3% 29.77% 16.67% 26.08% 26.46% 30.33% 16.62% 27.09% 28.33% 31.13%
Net Profit + 2 2 2 4 3 1 3 3 4 3 2 0 2
EPS in Rs 2 2 2 3 3 1 3 3 3 2 2 0 2
Raw PDF — — — — — — — — — — — — —
YoY Sales growth -1 9 13 3 13 -21 6 7 29 56 42 6 11

Source: Screener.in — figures in ₹ Crores unless marked %.

Profit & Loss (Yearly)

  Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
Sales + 103 71 95 106 109 95 90 163 168 189 188 249 259
Expenses + 91 61 82 95 99 89 80 140 145 165 161 221 236
Operating Profit 12 10 13 10 10 6 10 23 23 24 27 27 23
OPM % 12.0% 14.0% 14.0% 10.0% 9.0% 7.0% 11.0% 14.0% 14.0% 12.0% 14.0% 11.0% 9.0%
Other Income + 1 1 0 1 2 1 0 0 1 1 1 2 2
Interest 4 4 5 4 4 5 5 5 5 5 5 6 6
Depreciation 3 3 4 4 4 4 5 6 7 7 7 8 9
Profit before tax 5 3 5 3 5 -2 0 12 12 12 16 16 10
Tax % 22.0% 28.0% 22.0% 65.0% 28.0% 48.0% 350.0% 33.0% 30.0% 20.0% 26.0% 26.0% —
Net Profit + 4 3 4 1 3 -3 0 8 9 10 12 12 8
EPS in Rs 5 3 4 1 4 -3 0 8 8 8 10 10 7
Dividend Payout % 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% —
Sales growth 47 -31 33 11 3 -12 -6 81 3 13 -1 32 26

Source: Screener.in — figures in ₹ Crores unless marked %.

Balance Sheet

  Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Sep 2026
Reserves 17 19 23 24 27 24 24 38 51 60 72 84 86
Borrowings + 41 42 39 37 42 51 59 69 55 81 70 83 81
Other Liabilities + 17 10 15 18 17 23 15 36 28 38 37 50 70
Total Liabilities 83 79 86 87 95 107 106 153 145 190 190 228 249
Fixed Assets + 36 38 47 44 51 58 60 72 77 89 88 115 127
CWIP 1 2 0 0 0 3 5 3 2 21 29 11 7
Investments 1 1 0 0 0 0 0 0 0 0 0 0 0
Other Assets + 45 38 38 43 43 46 41 78 66 80 72 101 115
Total Assets 83 79 86 87 95 107 106 153 145 190 190 228 249
Equity Capital 8 8 8 8 8 8 8 10 11 11 11 11 11

Source: Screener.in — figures in ₹ Crores unless marked %.

Cash Flow

  Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Cash from Operating Activity + 0 3 16 13 9 9 6 9 21 16 32 8
Cash from Investing Activity + -4 -6 -10 -5 -11 -13 -7 -16 -10 -32 -16 -16
Cash from Financing Activity + 6 1 -5 -7 1 5 0 12 -14 15 -16 8
Net Cash Flow 1 -2 0 1 -1 0 0 4 -3 -1 0 0
Free Cash Flow -4 -3 5 8 -3 -4 0 -8 11 -16 16 -9
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 15 46 134 134 99 153 71 38 103 79 130 42

Source: Screener.in — figures in ₹ Crores unless marked %.

Shareholding Pattern

Quarter-by-quarter — Promoters, FII, DII & public holding trend

Promoter holding: 72.3% → 72.3%
  Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Public 27.7% 27.7% 27.7% 27.71% 27.71% 27.7% 27.7% 27.71% 27.7% 27.71% 27.71% 27.7%
Promoters 72.3% 72.3% 72.3% 72.3% 72.3% 72.3% 72.3% 72.3% 72.3% 72.3% 72.3% 72.3%

Source: Screener.in — quarterly shareholding disclosures.

Peers Comparison

Healthcare — ranked by market cap

Company Market Cap (Cr) P/E P/B ROE
Parnax Lab Ltd. (this stock) 125 14.6 1.27 14.2%
Bal Pharma Ltd. 135 17.1 1.58 7.79%
Alpa Laboratories Ltd 109 52.0 0.59 8.38%
Natural Capsules Limited 144 — 0.66 -9.45%
Vaishali Pharma Limited 95 21.4 1.33 5.83%
Makers Laboratories Ltd. 169 22.6 2.15 3.17%
Sunil Healthcare Ltd. 78 26.6 1.03 6.01%

Which Mutual Funds Hold Parnax Lab Ltd.?

Frequently Asked Questions about Parnax Lab Ltd.

Community Sentiment

What are other investors saying about Parnax Lab Ltd.?

No votes yet — be the first to share your view.

Sign in to vote

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

Sign in to join the discussion

No comments yet — start the discussion.